Morphic Holding, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
MORF Company Description
Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer.
MORF Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view MORF Smart Score
Score Breakdown
MORF Company Description
Show More
Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of MORF by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by MORF's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on MORF's company Twitter account
WallStreetBets
Number of mentions of MORF in WallStreetBets Daily Discussion
MORF News
Recent insights relating to MORF
CNBC Recommendations
Recent picks made for MORF stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in MORF
Corporate Flights
Flights by private jets registered to MORF
Our Analysis